ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 2604

$484K Total Retail Price of All Prescriptions

Rank: 236 out of 2604

412 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,573 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 552 277 S3 1 1
OMEPRAZOLE 365 188 2 5
LISINOPRIL 314 201 3 3
SIMVASTATIN 282 198 4 2
LEVOTHYROXINE SODIUM 281 202 5 4
METFORMIN HCL 267 132 6 7
FUROSEMIDE 217 184 7 8
METOPROLOL TARTRATE 203 164 8 9
GLIPIZIDE 184 115 9 51
WARFARIN SODIUM 178 106 10 13
AMLODIPINE BESYLATE 177 115 11 6
ATENOLOL 140 67 12 11
METOPROLOL SUCCINATE 128 89 13 17
POTASSIUM CHLORIDE 125 81 14 16
RANITIDINE HCL 113 51 15 25
SERTRALINE HCL 112 45 16 23
HYDROCHLOROTHIAZIDE 107 80 17 10
LOVASTATIN 104 44 18 24
GABAPENTIN 101 62 19 12
ISOSORBIDE MONONITRATE ER 86 76 20 38
TRIAMTERENE-HCTZ 80 67 21 55
TRAMADOL HCL 80 49 21 15
ZOLPIDEM TARTRATE 79 46 23 21
CLOPIDOGREL 76 54 24 39
TAMSULOSIN HCL 72 49 25 30
BUMETANIDE 70 42 26 70
OXYBUTYNIN CHLORIDE 69 21 27 92
KLOR-CON 10 68 21 28 173
CITALOPRAM HBR 66 29 29 18
ATORVASTATIN CALCIUM 65 55 30 19
PROAIR HFA 65 17 30 27
PREDNISONE 64 52 32 34
DIVALPROEX SODIUM 63 60 33 81
LANTUS 62 33 34 40
AMOXICILLIN 61 41 35 99
PLAVIX 59 46 36 75
ENALAPRIL MALEATE 59 43 36 50
PAROXETINE HCL 58 25 38 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 42 38 22
GEMFIBROZIL 56 27 40 87
MELOXICAM 54 23 41 36
ALLOPURINOL 53 38 42 35
CRESTOR 53 17 42 47
PRAVASTATIN SODIUM 52 41 44 14
JANUVIA 52 34 44 98
MIRTAZAPINE 52 26 44 52
IBUPROFEN 52 14 44 32
TORSEMIDE 51 14 48 177
ROPINIROLE HCL 51 22 48 102
CEPHALEXIN 51 38 48 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.